Skip to content
Chandra Bhagat Pharma logo

Chandra Bhagat Pharma

542934 BSE
Price unavailable

Chandra Bhagat Pharma (CBPL) share price was ₹47.18 at the 28 Oct 2026 close; market capitalisation ₹35.62 Cr; sector Healthcare. The share price rose 17.9% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Mar 2026 quarter, revenue was ₹91 Cr, against ₹22 Cr a year earlier and net profit was ₹3 Cr, against under ₹1 Cr a year earlier (compared with Mar 2025). Promoters held 73.02% of Chandra Bhagat Pharma in Sep 2026, unchanged from Mar 2026.

Close 28 Oct 2026 ₹47.18 +7.17 +17.92% 1Y

Key Fundamentals

SMEPharmaceuticals & BiotechnologyHealthcare
Market Cap
₹35.62 Cr
EBITDA
₹7.20 Cr
Return on Equity
9.2%
Debt to Equity
0.5
Book Value
₹43.90
EPS (TTM)
—
52W High
₹52.99
52W Low
₹29.70

Price-based figures as of 28 Oct 2026, 15:30 IST · TTM

Peer Comparison

Healthcare › Pharmaceuticals

Sun Pharma
₹1,768.0035.074,24,202 Cr5.080.91%13.79%17.94%61,848 Cr12,117 Cr
Divis Laboratories
₹9,657.5087.652,56,376 Cr15.300.32%15.32%18.96%11,682 Cr2,925 Cr
Torrent Pharmaceuticals
₹4,609.5072.361,75,331 Cr9.540.82%12.16%9.06%17,058 Cr2,156 Cr
Laurus Labs
₹2,187.70108.091,18,204 Cr22.300.09%16.38%19.67%7,323 Cr1,090 Cr
Zydus Life Science
₹1,181.6026.291,17,865 Cr4.350.09%16.99%19.24%28,515 Cr4,593 Cr
Dr Reddys Laboratories
₹1,339.0034.681,11,764 Cr2.880.61%10.87%13.94%34,247 Cr3,184 Cr
Cipla
₹1,365.5032.711,10,313 Cr3.120.96%11.21%14.88%28,589 Cr3,356 Cr
Chandra Bhagat Pharma (this company)
——36 Cr1.070.00%9.20%17.10%——
Median 8 companies₹1,768.0035.071,18,035 Cr4.720.47%12.98%17.52%28,515 Cr3,184 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100. How it works →

No Tapetide Score has been computed for this stock yet.

Key Insights

Strengths

3
  • Company has reduced debt.
  • Stock is trading at 0.91 times its book value
  • Promoter holding has increased by 0.83% over last quarter.

Weaknesses

5
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 10.5% over past five years.
  • Company has a low return on equity of 5.92% over last 3 years.
  • Earnings include an other income of Rs.3.35 Cr.
  • Company has high debtors of 171 days.

Technical Indicators

Oscillators

Bearish

Bearish
3
Neutral
6
Bullish
0

Overall

Bullish

Bearish
5
Neutral
6
Bullish
8

Moving Averages

Bullish

Bearish
2
Neutral
0
Bullish
8

Growth Rate

Revenue Growth
29.72% higher than 3Y

change over 1 year

Net Income Growth
233% higher than 3Y

change over 1 year

Cash Flow Change
262%

change over 1 year

EBITDA Margin Change
36.51%

change over 1 year Operating margin 2.4% · Mar 2026

Quarterly Results

Particulars Sep 2020Mar 2021Sep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales
22
48
43
51
44
75
119
102
65
22
26
91
Expenses
21
47
42
50
43
74
124
104
66
22
24
89
Operating Profit
2
2
2
1
1
2
-5
-2
-1
0
2
2
OPM %
7%
3.4%
3.8%
2.1%
2.3%
2.4%
-4.2%
-2%
-1.8%
-1.2%
7%
2.4%
Other Income
0
0
0
1
1
0
7
4
3
2
0
3
Interest
2
2
1
2
1
1
1
1
1
1
1
1
Depreciation
0
0
0
0
0
0
0
0
0
1
1
0
PBT
0
0
1
1
1
1
1
1
1
1
1
4
Tax %
25%
33%
24%
31%
31%
15%
32%
34%
-11%
69%
22%
26%
Net Profit
0
0
0
0
0
1
1
1
1
0
0
3
EPS (₹)
0.04
0.21
0.57
0.48
0.49
0.72
0.83
1.19
0.9
0.23
0.6
3.45
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
61
80
90
97
106
94
71
94
120
221
89
116
Expenses
58
76
85
92
102
91
67
91
116
228
88
112
Operating Profit
3
3
4
5
5
3
4
3
3
-7
1
4
OPM %
4.9%
4.3%
4.9%
4.7%
4.3%
3.3%
5%
3%
2.8%
-3.2%
0.7%
3.3%
Other Income
0
0
0
1
0
0
0
2
0
11
3
3
Interest
2
3
4
4
4
3
4
3
2
1
2
2
Depreciation
0
0
0
0
0
0
0
0
0
1
1
1
PBT
1
1
1
2
1
0
0
1
1
2
1
4
Tax %
39%
51%
27%
33%
22%
26%
32%
27%
22%
33%
26%
26%
Net Profit
0
0
1
1
1
0
0
1
1
2
1
3
EPS (₹)
1.3
1.06
2
3.12
1.28
0.41
0.25
1.06
1.21
2.03
1.14
4.04
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
0.42
0.42
0.42
0.42
0.67
8
8
8
8
8
8
8
Reserves
6
6
7
8
14
18
18
19
20
21
22
26
Borrowings
28
28
22
22
31
30
27
21
19
16
21
17
Other Liabilities
8
10
26
28
37
19
19
25
14
56
51
45
Total Liabilities
42
44
56
58
83
75
72
72
61
102
102
94
Fixed Assets
1
1
1
1
0
0
0
0
1
3
3
3
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
0
0
5
1
4
1
0
0
0
0
0
2
Other Assets
41
44
51
56
78
74
71
72
60
99
99
90
Total Assets
42
44
56
58
83
75
72
72
61
102
102
94
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0
0
-9
-6
4
-7
8
12
5
6
-6
9
Investing
0
0
0
0
0
0
0
0
0
-2
-1
0
Financing
0
0
8
7
-4
7
-6
-10
-4
-6
2
-6
Net Cash Flow
0
0
-1
0
0
0
2
3
1
-1
-4
2
Free Cash Flow
0
0
-9
-6
4
-7
8
12
5
4
-6
8
CFO/EBITDA
0
0
-200
-129
98
-238
229
440
164
-94
-805
250
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
71
66
80
67
90
54
80
58
25
65
148
171
Inventory Days
177
123
133
145
174
187
215
153
100
15
3
18
Days Payable
43
33
81
69
117
53
79
12
11
23
45
124
Cash Conversion Cycle
205
156
132
143
146
188
216
199
114
57
107
65
Working Capital Days
166
134
125
138
83
148
177
104
75
36
101
77
ROCE %
10%
10%
15%
17%
13%
7%
7%
9%
7%
8%
6%
12%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Chandra Bhagat Pharma insights

65 extracted metrics + investor summaries across FY15–FY26.

Shareholding Pattern

Promot.73.02%Public12.58%Others14.41%As ofSep 2026

Documents

Frequently Asked Questions about Chandra Bhagat Pharma

What does Chandra Bhagat Pharma Ltd do?
Incorporated in 2003, Chandra Bhagat Pharma Ltd manufactures chemical and pharmaceutical products.[1]
Where is Chandra Bhagat Pharma Ltd (CBPL) listed?
Chandra Bhagat Pharma Ltd trades under code 542934 on the BSE.
Which sector does Chandra Bhagat Pharma Ltd belong to?
Chandra Bhagat Pharma Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Chandra Bhagat Pharma Ltd?
Chandra Bhagat Pharma Ltd has a market capitalisation of ₹35.62 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the 52-week high and low of Chandra Bhagat Pharma Ltd?
Over the last 52 weeks Chandra Bhagat Pharma Ltd has traded between ₹29.7 and ₹52.99 as of 28 Oct 2026.
What is the Return on Equity (ROE) of Chandra Bhagat Pharma Ltd?
Chandra Bhagat Pharma Ltd reported a return on equity of 9.20%. Its debt-to-equity ratio is 0.50.

Company Information

Incorporated in 2003, Chandra Bhagat Pharma Ltd manufactures chemical and pharmaceutical products.[1]

Website cbcpharma.com
CEO Mr. Hemant Chandravadan Bhagat
Employees 40
Listed 2020-02-14
Face Value ₹ 10
Shares Outstanding 75,50,000

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/542934.md for Chandra Bhagat Pharma Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month